Drug Delivery Technologies Market
- Regional Insights
On the basis of region, the
global Drug
Delivery Technologies Market is segmented into North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa. North America holds
dominant position in the global drug delivery technologies market, owing to the
launch and adoption of novel technologies. For instance, in January 2019,
Amneal Pharmaceuticals received the U.S. Food and Drug Administration (FDA)
approval for its generic Exelon patch used for treatment of Alzheimer disease
through the transdermal drug delivery.
Drug delivery system is a method
in which the therapeutic substances are delivered through general route of
administration to obtain the therapeutic effect in humans or animals. The
correct dose of drugs release their functional ingredients in the targeted area
at the appropriate time. Drug delivery technologies helps to improve the absorption,
distribution, elimination, and drug release profile for developing the product
safety and efficiency. Drug delivery technologies are considered an important
aspect of pharmaceutical products which are often used by pharmaceutical
companies for extending the product’s lifecycle.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2690
Drug Delivery Technologies Market
Drivers
Increasing prevalence of chronic
diseases, growing demand for biologics, technological advancements, and new
product launches are some of the factors driving the growth of the market.
According to the National Center of Biotechnology Information (NCBI), in 2018,
around 45%, or 133 million, Americans were affected by one of the chronic
diseases.
Moreover, the Capsugel, a global
leader in delivering high quality, innovative dosage forms to the healthcare
industry, launches the new drug delivery system as per the commitment to
innovate for their costumer. For instance, in October 2015, Capsugel announced
the global commercial launch of its enTRinsic drug delivery technology, providing
full enteric protection and targeted release of gastric acid and heat sensitive
active ingredients to the upper gastrointestinal tract.
Furthermore, in April 2019,
Aquestive Therapeutics, Inc. announced that the U.S. Food and Drug
Administration (FDA) accepted the company’s New Drug Application (NDA) for
their investigational product, Riluzole oral film (ROF), which the company
intends to market under the brand name, Exservan. ROF is used for treatment of
amyotrophic lateral sclerosis (ALS). ROF is delivered through a postage stamp
sized film which dissolves in the mouth. The FDA had designated orphan drug
status to the drug in January 2018.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/drug-delivery-technologies-market-2690
However, risk factors such as
needle stick injuries and side effects of drugs are restricting the market
growth to a certain level. According to a 2014 estimate by the Occupational
Safety and Health Administration (OSHA), 5.6 million workers in the healthcare
industry are at a risk of needle sticks and sharps related injuries which
expose the workers to blood borne pathogens.
Drug Delivery Technologies Market
- Competitive Landscape
Key players operating in the
global drug delivery technologies market are focused on innovations related to
drug delivery technologies, in order to improve patient compliance. For
instance, in July 2018, Merck Pharmaceuticals and InnoCore Pharmaceuticals
entered into a global collaboration agreement for InnoCore’s proprietary
SynBiosys biodegradable polymer platform. The drug delivery technologies are
used to develop sustained release solutions for biologicals in injectable
formulations. The sustained release solutions play important role in drug
formulation because it improve the patient adherence.
Some of the key players operating
in the global drug delivery technologies market includes 3M, Bayer AG, Becton,
Dickinson & Company, Johnson & Johnson, Pfizer, Inc., Novartis AG,
Glaxosmithkline PLC, Vectura Group Plc., Roche Holding AG, Generex
Biotechnology, Antares Pharma, Inc., Alkermes, Merck & Co., Inc, and
Sanofi, Aradigm Corp.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2690
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment